Skip to main content
Clinical Trials/NCT02711358
NCT02711358
Completed
Phase 4

Rectal Indomethacin Use in Pain Relief During Intrauterine Device Insertion: A Randomized Controlled Trial

Assiut University1 site in 1 country120 target enrollmentMarch 2016

Overview

Phase
Phase 4
Intervention
indomethacin suppositories
Conditions
Family Planning
Sponsor
Assiut University
Enrollment
120
Locations
1
Primary Endpoint
Mean pain score during IUD insertion
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The aim of the investigators study is to test the analgesic effect of rectal indomethacin during Intrauterine device insertion.

Registry
clinicaltrials.gov
Start Date
March 2016
End Date
October 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ahmed Mohamed Abbas

Dr

Assiut University

Eligibility Criteria

Inclusion Criteria

  • Women not taken analgesics or anxiolytics in the 24 hours prior insertion
  • Women not taken misoprostol prior to intrauterine device insertion
  • Women who will accept to participate in the study

Exclusion Criteria

  • Any contraindication to intrauterine device placement

Arms & Interventions

indomethacin

indomethacin suppositories

Intervention: indomethacin suppositories

placebo

placebo suppositories

Intervention: placebo

Outcomes

Primary Outcomes

Mean pain score during IUD insertion

Time Frame: intraoperative

Study Sites (1)

Loading locations...

Similar Trials